BNB$659.57+0.51%BRENT$93.52-0.28%BTC$74,798+0.27%COPPER$6.54+1.21%DJI$52,759-1.32%DOGE$0.0820+1.09%DXY98.74-0.15%ETH$2,344-0.19%GOLD$4,546+0.67%NDX$29,213-0.72%SILVER$69.17+1.61%SOL$88.91-0.47%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%BNB$659.57+0.51%BRENT$93.52-0.28%BTC$74,798+0.27%COPPER$6.54+1.21%DJI$52,759-1.32%DOGE$0.0820+1.09%DXY98.74-0.15%ETH$2,344-0.19%GOLD$4,546+0.67%NDX$29,213-0.72%SILVER$69.17+1.61%SOL$88.91-0.47%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%
MoneyMarket365.comReal-time markets + AI-ranked and AI-analyzed financial news
·Confidence 75%

Bank of America Allocates $250 Million for GLP-1 Drugs

Key takeaways

  • Bank of America CEO reveals the bank spends $250 million annually on GLP-1 drugs for employees, highlighting rising demand for treatments like Ozempic and
#healthcare#pharmaceuticals#corporate spending

Analysis

Bank of America CEO reveals the bank spends $250 million annually on GLP-1 drugs for employees, highlighting rising demand for treatments like Ozempic and

0 likes · 0 dislikes

Comments & Replies

with Google or GitHub to join the discussion.

  • No comments yet be the first to share your view.